UCB - PE Price to Earnings


UCB reported 29.7 in PE Price to Earnings for its fiscal semester ending in December of 2025.





Pe Change Date
Alcon AG 36.42 1.77 Mar/2026
Almirall 79.43 0.3 Dec/2025
Amarin 91.05 88.3 Jun/2023
argenx SE 35.53 3.41 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Bayer 3.4 8.75 Mar/2026
Genmab 17.14 4.39 Dec/2025
GlaxoSmithKline 10.63 4.24 Jun/2026
GRIFOLS 14.71 3.73 Jun/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lakefront Biotherapeutics 2.54 0.6 Mar/2026
Lonza 34.34 2.58 Dec/2025
Merck 12.74 7.82 Mar/2026
Novartis 22.41 2.24 Jun/2026
Orion 17.23 1.3 Jun/2026
Recordati 22.75 5.09 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 18.96 7.12 Jun/2026
UCB 29.7 5.52 Dec/2025
Unibail Rodamco 10.36 0.43 Dec/2025